Paul joined the George Institute in 2018 as Chief Financial Officer. He has 20 years of international Healthcare experience in the areas of investor relations, finance, strategic planning, business development and licensing, manufacturing and supply chain, and procurement.
Previously Paul served as Chief Financial Officer for Mesoblast Ltd, a global leader in the field of cellular therapies. Prior to that Paul was the Country Chief Financial Officer for Novartis Australia and New Zealand. Previously he held a number of leadership roles with AstraZeneca in the UK, including Global Licensing Finance Director, before serving as Chief Financial Officer for AstraZeneca Australia.
Paul is a member of the Institute of Chartered Accountants in Australia, is a Fellow of the Institute of Chartered Accountants of England and Wales and has a Masters Degree in Engineering from Cambridge University. He has also undertaken executive leadership programs at the Harvard Business School and INSEAD.